(Q41442665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Alendronate treatment for osteoporosis: a review of the clinical evidence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

P Selby

series ordinal

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

419-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01629572

2 November 2019

exact match

0 references

cites work

Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.

1 reference

12 December 2020

Short-term effects on bone and mineral metabolism of 4-amino-1-hydroxybutylidene-1,1-diphosphonate (ABDP) in Paget's disease of bone

1 reference

12 December 2020

Design of the Fracture Intervention Trial

1 reference

12 December 2020

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

1 reference

12 December 2020

Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate

1 reference

12 December 2020

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

1 reference

12 December 2020

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

12 December 2020

Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate

1 reference

12 December 2020

The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Rationale for the use of alendronate in osteoporosis

1 reference

12 December 2020

Calcium requirement--a reappraisal of the methods used in its determination and their application to patients with osteoporosis

1 reference

12 December 2020

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

1 reference

12 December 2020

Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia

1 reference

12 December 2020

Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate

1 reference

12 December 2020

Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis

1 reference

12 December 2020

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone

1 reference

12 December 2020

The subcellular distribution of [14C]dichloromethylenebisphosphonate and [14C]1-hydroxyethylidene-1,1-bisphosphonate in cultured calvaria cells

1 reference

12 December 2020

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

1 reference

12 December 2020

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

1 reference

12 December 2020

The acute-phase response after bisphosphonate administration

1 reference

12 December 2020

The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin

1 reference

12 December 2020

Effects of five daily 1 h infusions of alendronate in Paget's disease of bone

1 reference

12 December 2020

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

1 reference

12 December 2020

Structure-activity relationships of various bisphosphonates

1 reference

12 December 2020

Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy

1 reference

12 December 2020

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

1 reference

12 December 2020

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1 reference

12 December 2020

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

1 reference

12 December 2020

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 reference

12 December 2020

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

12 December 2020

Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals

1 reference

12 December 2020

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01629572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9116385%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 November 2019

0 references

1 reference